Marc Tessier-Lavigne (Photo by Yichuan Cao/Sipa USA)(Sipa via AP Images)
September 11, 2023 07:45 AM EDTUpdated 09:59 AM
People

Marc Tessier-Lav­i­gne steps down from Re­gen­eron board

Lei Lei Wu

News Reporter

Marc Tessier-Lav­i­gne stepped down from Re­gen­eron’s board of di­rec­tors. The move comes af­ter he re­signed as Stan­ford Uni­ver­si­ty’s pres­i­dent fol­low­ing a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bris­tol My­ers prunes pipeline amid new round of cost cuts

Pfiz­er hires No­var­tis on­col­o­gy ex­ec to steer its can­cer am­bi­tions

As­traZeneca takes $753M charge on aban­doned com­ple­ment drug from Alex­ion deal

Bris­tol My­ers launch­es fresh round of ma­jor cost cuts in bid to get ahead of patent cliff

J&J, In­tra-Cel­lu­lar quick­ly sealed $14B deal as three oth­ers passed on buy­ing the neu­ro drug­mak­er

Up­dat­ed: Lil­ly posts 45% sales jump, culls four pro­grams across obe­si­ty, Alzheimer's, heart fail­ure and eczema

A service from the Financial Times